Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.
Panelists offer concluding insights and emphasize the critical role of comparative studies in advancing atopic dermatitis treatment strategies.
With hormonal fluctuations, constantly changing schedules, and various afterschool activities, addressing the specific needs of teenage skin becomes essential to promote a lifetime of proper skin care practices.
Smidt and Hunt offer insights on navigating pediatric dermatology decision-making, emphasizing learning from clinical scenarios and fostering a culture of feedback and improvement.
Karen S. Hsu Blatman, MD, shared key insights on biologics at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.
Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.
A presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.
Lindsey Zubritsky, MD, FAAD, discusses the importance of providing accurate eczema care education throughout the month of October.
Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
There are interesting differences in the ways patients of varying ethnicities and races engage with technology.
The sweeping legislation contains tax code reform, health care provisions and climate change action. What does it mean for physicians?
In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.
Hasbargen presented Mohs surgery pearls on closure types and pattern recognition at the 2024 Diversity in Dermatology meeting.
Nicole Vélez, MD, provided marketing pearls to streamline mundane tasks and promote your practice in the digital world.
Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
A presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.
Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.
Sarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.
Boehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.
Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.
Take a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
Researchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.
Experts describe roflumilast patient selection for plaque psoriasis treatment.